Category: Allgemein

Pre-scheduled safety review after 12 patients: Data Monitoring Committee recommends continuation of the trial as planned.

First patient dosed in Phase 2 ADCAP trial to treat severe cases of pneumonia. The double-blind, placebo-controlled trial will recruit 100 patients in five European countries.

First closing of Series B financing round

Multiple ascending dose study with AON-D21 completed

Single ascending dose study with AON-D21 completed

First healthy volunteer dosed with AON-D21

German Medicines Agency BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte) approved the First-in-Human study with AON-D21

Germany’s Education and Research Minister announced to significantly fund the further development of AON-D21 by the Federal Covid-19 initiative (FKZ16LW0006).

Series A2 1st Closing successfully completed by registration of the capital increase in the commercial register